In an attempt to develop novel inhibitors of the NLRP3 inflammasome acting on NEK7, we identified an NLRP3 inhibitor blocking NEK7 binding to NLRP3 and investigated its effect on an MSU-induced gout animal model, which mimics human gout arthritis pathogenically linked to the inflammasome. Here, NLRP3 is linked to gout.